SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cisco who wrote (1868)2/4/1999 1:39:00 PM
From: Frank Buck  Read Replies (1) of 1894
 
This place looks like a ghost town.

Has anyone any idea how big the illicit opiate dependency remediation market is?? A friend told me about this company and aside from the article depicted below I can't find spit on it.

I have heard that the illicit opiate class drugs have made a HUGE come-back in popularity. What's anyones take on this technology and the prospects for them amounting to anything in terms of their 24 hour turn around technology?

Seems to have gotten some decent press coverage but again aside from the article I am without info.... other than it is destined to become a fore front leader as a remedial technology with a subsequent upward move in share price. Any ideas one way or the other?

I must admit the ticker symbol.... DTOX is certainly interesting. Do you think that insurance providers would provide coverage for this process like some do for other substance abuses?

Thanks

CITA Biomedical, Inc. Announces New Hospital Opening; Also to be Featured on ABC's 'General Hospital'

PR Newswire - December 14, 1998 16:18

FORT LEE, N.J. and BEVERLY HILLS, Calif., Dec. 14 /PRNewswire/ -- Joseph Dunn, president of CITA Biomedical, Inc. (OTC Bulletin Board: DTOX) today announced the scheduled opening of Centinela Hospital in Los Angeles on January 2, 1999, whereby Centinela will begin to detoxify opiate based addicted persons utilizing the proprietary CITA/UROD (Ultra Rapid Opiate Detoxification) method.

The CITA method has been successfully applied to detox over 5,000 patients throughout Europe and the Middle East. More than 600 patients have been treated successfully in the United States where the procedure is performed by Board Certified Anesthesiologists in a hospital while the patient is asleep under anesthesia. Patients undergoing CITA's exclusive UROD procedure generally require no more than a 24 hour hospital stay.

The UROD method has been covered in the national media. This week, ABC's "General Hospital" will feature the CITA/UROD method as its main storyline, whereby its main character (Dr. Alan Quartermine) will be detoxed from the addiction to narcotic painkillers, culminating the one and a half year theme.

Adding to "ER" and "Chicago Hope," "General Hospital" becomes the latest medically oriented television show to create a storyline around CITA's revolutionary UROD detoxification method. ABC's "20/20" and FOX News, Discover Wall Street, among others have also featured the company.

Centinela Hospital joins Mount Sinai Medical Center of Miami Beach, University of Illinois Medical Center and a soon to be announced facility in the North East, in the nationwide effort to detoxify and rehabilitate addicts.

SOURCE CITA Biomedical, Inc.

/CONTACT: Investor - Judy Ryon of Global Consultants, 310-859-9725; or
Media - Bill Campbell of Campbell & Fitzgibbons, Inc., 201-200-5505, for CITA
Biomedical/

(DTOX)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext